A Study of ML-004 in Adolescents and Adults with Autism Spectrum Disorder
- Ages 12-45.
- Diagnosis of autism spectrum disorder.
- Able to attend all visits with a study partner.
- Verbal and able to swallow a capsule.
- If you have history of medical issues such as seizures, blood disorders, or other major health conditions you may not qualify for this trial.
- Open-label study to follow.
- Method of Administration : Oral / Capsule
- Length/Duration: 12 weekly / biweekly visits
- Location: 721 North Magnolia Avenue, Orlando FL 32803
- Compensation: $50 / visit
- Participants may:
- See a doctor or medical staff at no cost
- Have access to trial medications
- Receive compensation for time and travel